Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Philip Molyneaux, MD
Royal Brompton & Harefield NHS Foundation Trust
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medical University of Vienna
Vienna, Austria
- E Pne Uz Leuven
Leuven, Belgium
- Chu de Liège
Liège, Belgium
- Pneumologicka Klinika 1.Lf Uk A
Prague, Czechia
- Azienda Ospedaliero-Universitaria "ospedali-Riuniti" Di Ancona
Ancona, Italy
- Azienda Ospedaliero Universitaria Policlinico ''G.Rodolico-San Marco''
Catania, Italy
- Colonello D'Avanzo Hospital
Foggia, Italy
- Po Vito Fazzi
Lecce, Italy
- Ospedale S. Giuseppe Milano
Milan, Italy
- Azienda Ospedaliera Universitaria of Modena
Modena, Italy
- Fondazione Policlinico Universitario A. Gemelli
Roma, Italy
- Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy
- University Clinical Centre in Gdansk
Gdansk, Poland
- Barlicki University Hospital
Lodz, Poland
- Institute of Tuberculosis and Lung Diseases in Warsaw
Warsaw, Poland
- Hospital Universitario Clínic de Barcelona
Barcelona, Spain
- L'Hospital Universitari de Bellvitge
Barcelona, Spain
- Policlinica Barcelona
Barcelona, Spain
- Hospital Universitario la Paz
Madrid, Spain
- Hospital Universitario Central de Asturias
Oviedo, Spain
- Hospital Universitario Marqués de Valdecilla
Santander, Spain
- Hospital Clínico Universitario de Santiago de Compostela
Santiago de Compostela, Spain
- University Hospital of Geneve
Geneva, Switzerland
- Belfast City Hospital
Belfast, United Kingdom
- Queen Elizabeth Hospital
Birmingham, United Kingdom
- Royal Papworth Hospital Nhsft
Cambridge, United Kingdom
- Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
- Guy'S Hospital
London, United Kingdom
- Royal Brompton Hospital
London, United Kingdom
- Altnagelvin Area Hospital
Londonderry, United Kingdom
- Churchill Hospital, Oxford University Hospitals Nhs Trust
Oxford, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2022
- Primary completion
- 25 Jun 2024
- Completion
- 9 Jan 2025
- Last update posted
- 23 Aug 2024
- Registered enrollment
- 48
- Registry id
- NCT05570058
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.